Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

3,967 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Role of Liquid Biopsies in Detecting Molecular Tumor Biomarkers in Brain Cancer Patients.
Sareen H, Garrett C, Lynch D, Powter B, Brungs D, Cooper A, Po J, Koh ES, Vessey JY, McKechnie S, Bazina R, Sheridan M, Gelder JV, Darwish B, Jaeger M, Roberts TL, De Souza P, Becker TM. Sareen H, et al. Among authors: cooper a. Cancers (Basel). 2020 Jul 8;12(7):1831. doi: 10.3390/cancers12071831. Cancers (Basel). 2020. PMID: 32650387 Free PMC article. Review.
Ring a ring o'roses, a patient with Kaposi's? Pazopanib, pazopanib, it might go away. Mediterranean (classic) Kaposi sarcoma responds to the tyrosine kinase inhibitor pazopanib after multiple lines of standard therapy.
Harris BHL, Walsh JL, Neciunaite R, Manders P, Cooper A, De Souza P. Harris BHL, et al. Among authors: cooper a. Clin Exp Dermatol. 2018 Mar;43(2):234-236. doi: 10.1111/ced.13302. Epub 2017 Dec 28. Clin Exp Dermatol. 2018. PMID: 29282751 No abstract available.
Pembrolizumab for anaplastic thyroid cancer: a case study.
Aghajani MJ, Cooper A, McGuire H, Jeffries T, Saab J, Ismail K, de Souza P, Bray V, Fazekas de St Groth B, Niles N, Roberts TL. Aghajani MJ, et al. Among authors: cooper a. Cancer Immunol Immunother. 2019 Dec;68(12):1921-1934. doi: 10.1007/s00262-019-02416-7. Epub 2019 Oct 22. Cancer Immunol Immunother. 2019. PMID: 31637475 Free PMC article.
Human TERT promoter mutations as a prognostic biomarker in glioma.
Powter B, Jeffreys SA, Sareen H, Cooper A, Brungs D, Po J, Roberts T, Koh ES, Scott KF, Sajinovic M, Vessey JY, de Souza P, Becker TM. Powter B, et al. Among authors: cooper a. J Cancer Res Clin Oncol. 2021 Apr;147(4):1007-1017. doi: 10.1007/s00432-021-03536-3. Epub 2021 Feb 6. J Cancer Res Clin Oncol. 2021. PMID: 33547950 Free PMC article. Review.
PD-L1 Detection on Circulating Melanoma Cells.
Po JW, Ma Y, Balakrishnar B, Brungs D, Azimi F, Cooper A, Saricilar E, Murthy V, de Souza P, Becker TM. Po JW, et al. Among authors: cooper a. Methods Mol Biol. 2021;2265:223-233. doi: 10.1007/978-1-0716-1205-7_17. Methods Mol Biol. 2021. PMID: 33704718
From Pediatric to Adult Brain Cancer: Exploring Histone H3 Mutations in Australian Brain Cancer Patients.
Grebstad Tune B, Sareen H, Powter B, Kahana-Edwin S, Cooper A, Koh ES, Lee CS, Po JW, McCowage G, Dexter M, Cain L, O'Neill G, Prior V, Karpelowsky J, Tsoli M, Baumbusch LO, Ziegler D, Roberts TL, DeSouza P, Becker TM, Ma Y. Grebstad Tune B, et al. Among authors: cooper a. Biomedicines. 2023 Oct 27;11(11):2907. doi: 10.3390/biomedicines11112907. Biomedicines. 2023. PMID: 38001908 Free PMC article.
A phase I trial to determine safety and pharmacokinetics of ASLAN002, an oral MET superfamily kinase inhibitor, in patients with advanced or metastatic solid cancers.
Roohullah A, Cooper A, Lomax AJ, Aung J, Barge A, Chow L, McHale M, Desai J, Whittle JR, Tran B, de Souza P, Horvath LG. Roohullah A, et al. Among authors: cooper a. Invest New Drugs. 2018 Oct;36(5):886-894. doi: 10.1007/s10637-018-0588-7. Epub 2018 May 16. Invest New Drugs. 2018. PMID: 29766337 Clinical Trial.
3,967 results